His primary areas of investigation include Surgery, Radiation therapy, Internal medicine, Medulloblastoma and Chemotherapy. His Surgery research includes themes of Pediatrics and Glioma. His Glioma research incorporates themes from Radiology, Neurofibromatosis and Neuroscience.
Roger J. Packer has researched Radiation therapy in several fields, including Lomustine, Cancer and Regimen. His studies in Internal medicine integrate themes in fields like Gastroenterology, Oncology and Pathology. His research in Medulloblastoma intersects with topics in Clinical trial, Quality of life, Primitive neuroectodermal tumor, Proportional hazards model and Disease.
His primary scientific interests are in Internal medicine, Surgery, Oncology, Pathology and Radiation therapy. The study incorporates disciplines such as Medulloblastoma and Glioma in addition to Internal medicine. He has researched Medulloblastoma in several fields, including Disease and Primitive neuroectodermal tumor.
His Surgery study combines topics from a wide range of disciplines, such as Toxicity, Pediatrics and Neurofibromatosis. His Pathology research incorporates themes from Astrocytoma and Central nervous system. As part of one scientific family, Roger J. Packer deals mainly with the area of Radiation therapy, narrowing it down to issues related to the Chemotherapy, and often Regimen.
Roger J. Packer spends much of his time researching Internal medicine, Oncology, Clinical trial, Glioma and Neurofibromatosis. His work in the fields of Pediatric Neuro-Oncology overlaps with other areas such as Isotretinoin. His biological study spans a wide range of topics, including Medulloblastoma, BRAF V600E, Chemotherapy and Low-Grade Glioma.
His Chemotherapy study frequently links to adjacent areas such as Radiation therapy. Roger J. Packer has included themes like Cancer, Precision medicine, Magnetic resonance imaging and Progression-free survival in his Glioma study. The Neurofibromatosis study combines topics in areas such as Cabozantinib, Cognition, Everolimus, Prospective cohort study and Pediatrics.
His main research concerns Internal medicine, Clinical trial, Glioma, Oncology and Neurofibromatosis. Internal medicine and In patient are two areas of study in which Roger J. Packer engages in interdisciplinary work. His studies deal with areas such as Cancer, Pediatric Neuro-Oncology, MEDLINE, Disease and Response assessment as well as Clinical trial.
His study focuses on the intersection of Response assessment and fields such as Confounding with connections in the field of Medulloblastoma. His studies in Glioma integrate themes in fields like Targeted therapy, Magnetic resonance imaging, Biopsy and Consensus conference. His work carried out in the field of Oncology brings together such families of science as Exome sequencing, Precision medicine, MEK inhibitor and BRAF V600E.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity
Lucy Balian Rorke;Roger J. Packer;Jaclyn A. Biegel.
Journal of Neurosurgery (1996)
Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study
Paul M. Zeltzer;James M. Boyett;Jonathan L. Finlay;A. Leland Albright.
Journal of Clinical Oncology (1999)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Roger J. Packer;Amar Gajjar;Gilbert Vezina;Lucy Rorke-Adams.
Journal of Clinical Oncology (2006)
Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study
Roger J. Packer;Joel Goldwein;H. Stacy Nicholson;L. Gilbert Vezina.
Journal of Clinical Oncology (1999)
New Primary Neoplasms of the Central Nervous System in Survivors of Childhood Cancer: a Report From the Childhood Cancer Survivor Study
Joseph P. Neglia;Leslie L. Robison;Marilyn Stovall;Yan Liu.
Journal of the National Cancer Institute (2006)
The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research
Leslie L. Robison;Gregory T. Armstrong;John D. Boice;Eric J. Chow.
Journal of Clinical Oncology (2009)
Intellectual Outcome After Reduced-Dose Radiation Therapy Plus Adjuvant Chemotherapy for Medulloblastoma: A Children’s Cancer Group Study
M. Douglas Ris;Roger Packer;Joel Goldwein;Dana Jones-Wallace.
Journal of Clinical Oncology (2001)
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas
Roger J. Packer;Joanne Ater;Jeffrey Allen;Peter Phillips.
Journal of Neurosurgery (1997)
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy
Packer Rj;Sutton Ln;Elterman R;Lange B.
Journal of Neurosurgery (1994)
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
Tobey J. MacDonald;Kevin M. Brown;Kevin M. Brown;Bonnie Lafleur;Katia Peterson.
Nature Genetics (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: